LEADER 03298nam 2200613 a 450 001 9910643797703321 005 20230213211652.0 010 $a1-280-76863-0 010 $a9786613679406 010 $a0-470-71911-7 010 $a0-470-71658-4 035 $a(CKB)1000000000687272 035 $a(EBL)703757 035 $a(OCoLC)775867306 035 $a(SSID)ssj0000715107 035 $a(PQKBManifestationID)11472275 035 $a(PQKBTitleCode)TC0000715107 035 $a(PQKBWorkID)10700055 035 $a(PQKB)11161222 035 $a(MiAaPQ)EBC703757 035 $a(EXLCZ)991000000000687272 100 $a19851218d1958 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation Symposium on Amino Acids and Peptides with Antimetabolic Activity$b[electronic resource] /$feditors for the Ciba Foundation, G.E.W. Wolstenholme and Cecilia M. O'Connor 210 $aBoston $cLittle, Brown and Co.$d[1958] 215 $a1 online resource (308 p.) 225 1 $aNovartis Foundation Symposia ;$vv.898 300 $aDescription based upon print version of record. 311 $a0-470-72255-X 320 $aIncludes bibliographical references and indexes. 327 $aAMINO ACIDS AND PEPTIDES WITH ANTIMETABOLIC ACTIVITY; CONTENTS; Chairman's opening remarks; The stereochemistry of naturally occurring b-amino acids; Discussion; The mode of action of chloramphenicol; Discussion; A preliminary study of the influence of amino acid deficiencies on experimental cancer chemotherapy; Discussion; Some aspects of azaserine, 6-diazo-5-oxo-L-norleucine and b-2-thienylalanine; The interference of azaserine in purine biosynthesis; Discussion; Amino acid and peptide derivatives with potential antitumour properties 327 $aClinical effects of amino acids carrying nitrogen mustard groupsFurther clinical observations on p-di(2-chloroethyl)amino-DL-phenylalanine (sarcolysine) in comparison with some other chloroethylamine derivatives; Discussion; Recent developments in actinomycin chemistry; Discussion; Clinical and biological studies with actinomycins; Discussion; The chemistry of etamycin; Discussion; The aminoacyl insertion reaction and peptide chemistry; Discussion; Synthesis of cyclic polypeptides; Discussion; General Discussion; Disulphide crosslinking in cysteine peptides; Discussion 327 $aStructure and function of some sulphur-containing peptidesDiscussion; Bacitracin; Discussion; Oxidative formation of biologically active compounds from peptides; Discussion; General Discussion; Chairman's closing remarks 410 0$aNovartis Foundation Symposia 606 $aAntimetabolites$vCongresses 606 $aAmino acids$vCongresses 606 $aPeptides$vCongresses 615 0$aAntimetabolites 615 0$aAmino acids 615 0$aPeptides 676 $a547.75 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 701 $aO'Connor$b Cecilia M$g(Cecilia Mary),$f1927-$0207754 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910643797703321 996 $aCiba Foundation Symposium on Amino Acids and Peptides with Antimetabolic Activity$93004935 997 $aUNINA